Alexander V. Ivashchenko
Rabochaya St. 2a, Khimki
Moscow, MOW 141401, Russian Federation
Moscow, MOW 141401, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: February 11, 2020
Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs).
Journal: European journal of medicinal chemistry
Published: October 07, 2019
Antiviral activity in vitro and pharmacokinetics of HCV entry inhibitor AVR560
Journal: Eksperimental'naia i klinicheskaia farmakologiia
Published: December 19, 2014
Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics
Journal: Eksperimental'naia i klinicheskaia farmakologiia
Published: August 01, 2014
Preclinical study of the new anti-influenza drug candidate AV0038 (ethyl 2-(dimethylaminomethyl)-5-hydroxy-1-methyl-6-(pyridin-3-yl)-1H-indole-3-carboxylate)
Journal: Eksperimental'naia i klinicheskaia farmakologiia
Published: July 19, 2014
Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C
Journal: Eksperimental'naia i klinicheskaia farmakologiia
Published: January 01, 2014
Showing 1-6 of 6
Last Updated: 09/26/2026